Tonix Pharmaceuticals Holding Corp (TNXP)
0.19
-0.01
(-6.95%)
USD |
NASDAQ |
Nov 22, 16:00
0.1807
-0.01
(-4.89%)
After-Hours: 20:00
Tonix Pharmaceuticals Free Cash Flow: -69.19M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -69.19M |
| June 30, 2024 | -75.58M |
| March 31, 2024 | -90.87M |
| December 31, 2023 | -109.90M |
| September 30, 2023 | -114.09M |
| June 30, 2023 | -121.25M |
| March 31, 2023 | -131.65M |
| December 31, 2022 | -146.20M |
| September 30, 2022 | -167.30M |
| June 30, 2022 | -155.64M |
| March 31, 2022 | -140.56M |
| December 31, 2021 | -110.86M |
| September 30, 2021 | -81.24M |
| June 30, 2021 | -79.85M |
| March 31, 2021 | -69.37M |
| December 31, 2020 | -57.13M |
| September 30, 2020 | -45.37M |
| June 30, 2020 | -32.72M |
| March 31, 2020 | -27.38M |
| December 31, 2019 | -26.70M |
| September 30, 2019 | -26.84M |
| June 30, 2019 | -25.08M |
| March 31, 2019 | -25.85M |
| December 31, 2018 | -23.98M |
| September 30, 2018 | -22.08M |
| Date | Value |
|---|---|
| June 30, 2018 | -22.24M |
| March 31, 2018 | -21.11M |
| December 31, 2017 | -19.13M |
| September 30, 2017 | -19.64M |
| June 30, 2017 | -22.99M |
| March 31, 2017 | -26.62M |
| December 31, 2016 | -37.38M |
| September 30, 2016 | -43.90M |
| June 30, 2016 | -47.87M |
| March 31, 2016 | -49.26M |
| December 31, 2015 | -42.77M |
| September 30, 2015 | -39.15M |
| June 30, 2015 | -31.80M |
| March 31, 2015 | -28.15M |
| December 31, 2014 | -23.16M |
| September 30, 2014 | -18.35M |
| June 30, 2014 | -16.21M |
| March 31, 2014 | -11.24M |
| December 31, 2013 | -8.532M |
| September 30, 2013 | -6.500M |
| June 30, 2013 | -4.931M |
| March 31, 2013 | -5.333M |
| December 31, 2012 | -5.749M |
| September 30, 2012 | -5.71M |
| June 30, 2012 | -4.966M |
Free Cash Flow Range, Past 5 Years
-167.30M
Minimum
Sep 2022
-26.70M
Maximum
Dec 2019
-92.64M
Average
-86.06M
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.486B |
| Emergent BioSolutions Inc | 138.10M |
| Geovax Labs Inc | -27.24M |
| Amicus Therapeutics Inc | -31.51M |
| Chimerix Inc | -70.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.80M |
| Cash from Investing (Quarterly) | -0.009M |
| Cash from Financing (Quarterly) | 42.90M |
| Free Cash Flow Per Share (Quarterly) | -0.3028 |
| Free Cash Flow to Equity (Quarterly) | -18.31M |
| Free Cash Flow Yield | -2.06K% |